Business · 23/04/2014
FDA Releases Guidance on Monoclonal Antibody Products Under Orphan Drug Regulations
The Food and Drug Administration (FDA) has published a guidance document to help industry understand the criteria for determining sameness of monoclonal antibody products under the Orphan Drug Act and related regulations.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →